EvaluatePharma has just released their Orphan Drug Report 2015. This free report contains tons of great information on the current state of the market. A few highlights below: - Median cost per patient differential is 13.8 times higher for orphan drugs compared to non-orphan - Phase III orphan drug development costs half that of non-orphan but Phase III drug development - Worldwide orphan drug sales forecast to total $178bn (CAGR 2015 to 2020: +11.7%); nearly double the ove

We talk about the FIRST organization quite a bit here at Patagonia. They are an incredible resource for patients and supporters. To learn more about their organization, check out their newly released video: https://www.youtube.com/watch?v=8laUeY_i9XM #first #ichthyosis #raredisease #skin #video #nonprofit #foundation #patagonia #patient

We'll be attending the 2015 RxAdherence conference in Florham Park, NJ on Tuesday, 3/31. The conference is focused on improving patient adherence and compliance through appropriate packaging, a topic not to be underestimated! #rxadherence #packaging #compliance #adherence #drug #patient #topical